Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias
Journal of the American Heart Association · 21.05.2024 · 13 (10)
DOI: 10.1161/jaha.123.030467 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the American Heart Association, erschienen am 21.05.2024. Verfasst von Joyce C Ohiri und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genetic Medicine, Feinberg School of Medicine Northwestern University Chicago IL USA. Hauptthemen laut MEDLINE: Filamins, Proteostasis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Many cardiomyopathy‐associated FLNC pathogenic variants are heterozygous truncations, and FLNC pathogenic variants are associated with arrhythmias. Arrhythmia triggers in filaminopathy are incompletely understood. Methods and Results We describe an individual with biallelic FLNC pathogenic variants, p.Arg650X and c.970‐4A>G, with peripartum cardiomyopathy and ventricular arrhythmias. We also describe clinical findings in probands with FLNC variants including Val2715fs87X, Glu2458Serfs71X, Phe106Leu, and c.970‐4A>G with hypertrophic and dilated cardiomyopathy, atrial fibrillation, and ventricular tachycardia. Induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) were generated. The FLNC truncation, Arg650X/c.970‐4A>G, showed a marked reduction in filamin C protein consistent with biallelic loss of function mutations. To assess loss of filamin C, gene editing of a healthy control iPSC line was used to generate a homozygous FLNC disruption in the actin binding domain. Because filamin C has been linked to protein quality control, we assessed the necessity of filamin C in iPSC‐CMs for response to the proteasome inhibitor bortezomib. After exposure to low‐dose bortezomib, FLNC‐ null iPSC‐CMs showed an increase in the chaperone proteins BAG3, HSP70 (heat shock protein 70), and HSPB8 (small heat shock protein B8) and in the autophagy marker LC3I/II. FLNC null iPSC‐CMs had prolonged electric field potential, which was further prolonged in the presence of low‐dose bortezomib. FLNC null engineered heart tissues had impaired function after low‐dose bortezomib.
Conclusions
FLNC pathogenic variants associate with a predisposition to arrhythmias, which can be modeled in iPSC‐CMs. Reduction of filamin C prolonged field potential, a surrogate for action potential, and with bortezomib‐induced proteasome inhibition, reduced filamin C led to greater arrhythmia potential and impaired function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genetic Medicine, Feinberg School of Medicine Northwestern University Chicago IL USA.
- Feinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine Northwestern University Chicago IL USA.
- Bluhm Cardiovascular Institute Northwestern Medicine Chicago IL USA.
- Cell and Molecular Physiology Loyola University Stritch School of Medicine Maywood IL USA.
- Department of Pharmacology, Feinberg School of Medicine Northwestern University Chicago IL USA.
ORCID-Profile: Lisa Dellefave-Castillo, Garima Tomar, Lisa Wilsbacher, Lubna Choudhury, David Y Barefield, Dominic Fullenkamp, Tanner O Monroe, Lorenzo Pesce, Malorie Blancard, Lauren Vaught, Alfred L George, Megan J Puckelwartz, Elizabeth M McNally
Förderung
- NHLBI NIH HHS
- NIH HHS
Zitieren
APA
Ohiri, J. C., Dellefave-Castillo, L., Tomar, G., Wilsbacher, L., Choudhury, L., Barefield, D. Y., Fullenkamp, D., Gacita, A. M., Monroe, T. O., Pesce, L., Blancard, M., Vaught, L., George, A. L., Demonbreun, A. R., Puckelwartz, M. J., & McNally, E. M. (2024). Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias. Journal of the American Heart Association, 13(10). https://doi.org/10.1161/jaha.123.030467
Vancouver
Ohiri JC, Dellefave-Castillo L, Tomar G, Wilsbacher L, Choudhury L, Barefield DY, et al. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias. Journal of the American Heart Association. 2024;13(10). doi:10.1161/jaha.123.030467
BibTeX
@article{Ohiri2024,
author = {Ohiri, Joyce C and Dellefave-Castillo, Lisa and Tomar, Garima and Wilsbacher, Lisa and Choudhury, Lubna and Barefield, David Y and Fullenkamp, Dominic and Gacita, Anthony M and Monroe, Tanner O and Pesce, Lorenzo and Blancard, Malorie and Vaught, Lauren and George, Alfred L and Demonbreun, Alexis R and Puckelwartz, Megan J and McNally, Elizabeth M},
title = {Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {10},
doi = {10.1161/jaha.123.030467}
}
EUVIMED